Last edition
News about
GSK Reports Positive Phase 3 Results for Bepirovirsen in Chronic Hepatitis B Treatment
GSK’s investigational antisense oligonucleotide bepirovirsen demonstrated statistically significant functional cure rates in chronic hepatitis B patients, offering a potential alternative to lifelong antiviral therapy.
Aptar Pharma Files Patents, Reports Positive Preclinical Data for GLP-1 Nasal and Pulmonary Delivery
Aptar Pharma announced new patent applications and positive preclinical data supporting intranasal and pulmonary GLP-1 delivery, expanding its capabilities in inhaled and intranasal biologic drug delivery.
SK Bioscience’s partnership with VECOL positions SK bioscience as a strategic technology transfer partner in Colombia’s national vaccine self-sufficiency initiative, supporting local manufacturing, public health preparedness and regional supply resilience.
Indoco Remedies Secures EU GMP Certification for Baddi Formulation Plant III
Indoco Remedies has received EU GMP certification for its Baddi Plant III formulation facility following a successful inspection conducted in April 2026.
Caliway Biopharmaceuticals secures US FDA IND clearance for CBL-0302, a global phase 3 clinical trial evaluating CBL-514 for non-surgical abdominal fat reduction.
The Lupus Research Alliance and Genentech announce inaugural recipients of the Immune Resetting Therapies for Lupus Award to accelerate research into CAR-T cell therapies for severe lupus patients.
Biocytogen Launches AI-Powered RenSuper Platform to Accelerate Therapeutic Antibody Discovery
Biocytogen unveils RenSuper, a next-generation AI-driven antibody discovery and automation platform designed to streamline therapeutic biologics development and accelerate the delivery of innovative medicines worldwide.
Consultative Meeting on WHO-ICHI Framework and Traditional Medicine Health Codes Concludes
India’s Ministry of Ayush held a two-day consultative meeting on the World Health Organization (WHO)-ICHI framework and National Health Intervention Codes to advance standardised coding systems for Ayurveda, Siddha, and Unani practices under global traditional medicine classification initiatives.
Lupin Receives US FDA EIR for Ankleshwar Manufacturing Facility
Lupin has received an Establishment Inspection Report (EIR) from the US Food and Drug Administration (FDA) for its Ankleshwar facility following the successful closure of a product-specific pre-approval inspection conducted in March 2026.
Asahi Kasei Life Science Acquires License for Novel ADC Technology from The Noguchi Institute
Asahi Kasei Life Science Secures Rights to Novel Antibody Drug Conjugate (ADC) Technology from The Noguchi Institute to Advance Safer and More Efficient Cancer Therapies
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy